Skip to main content

Together we are beating cancer

Donate now

Research and trials

Showing 12 out of 1644 results
A medical professional holding a tube containing a blood sample

Researchers in Manchester have developed CUPiD, a blood test that could transform the diagnostic journey of someone with cancer of unknown primary. Researchers in Manchester have developed CUPiD, a blood test that could transform the diagnostic journey of someone with cancer of unknown primary.

by Jacob Smith | In depth | 23 April 2024

23 April 2024

Professor Iain McNeish

Clinician scientists are vital in bridging the gap between discovery research and the patient. So how do we continue to attract medics to research? Clinician scientists are vital in bridging the gap between discovery research and the patient. So how do we continue to attract medics to research?

by Phil Prime | Interview | 5 April 2024

5 April 2024

This entry is part 12 of 12 in the series Research Integrity
Several disposable e-cigarettes in different colours

You may have seen media coverage of a study that looked at changes in different types of cells from people who smoked and people who vaped. Let's break down what the results really show. You may have seen media coverage of a study that looked at changes in different types of cells from people who smoked and people who vaped. Let's break down what the results really show.

by Julia Cotterill | Analysis | 20 March 2024

20 March 2024

A male patient with a female doctor during an appointment

Fewer middle-aged people are dying from cancer in the UK than at any point over the last 25 years, a new study from Cancer Research UK has revealed Fewer middle-aged people are dying from cancer in the UK than at any point over the last 25 years, a new study from Cancer Research UK has revealed

by Jacob Smith | News | 14 March 2024

14 March 2024

Prostate Cancer cell image taken using a Scanning Electron Microscope

Research published in Cell Genomics today has shown that prostate cancer, which affects one in six men in the UK in their lifetime, includes two different subtypes of the disease, also known as evotypes. Research published in Cell Genomics today has shown that prostate cancer, which affects one in six men in the UK in their lifetime, includes two different subtypes of the disease, also known as evotypes.

by Amy Warnock | News | 29 February 2024

29 February 2024

Cancer cell dividing

Getting to grips with metastasis means understanding the evolutionary mechanisms behind this complex biology, says Dr Simone Zaccaria... Getting to grips with metastasis means understanding the evolutionary mechanisms behind this complex biology, says Dr Simone Zaccaria...

by Cancer Research UK | In depth | 27 February 2024

27 February 2024

A scientist carrying out clinical research in the lab.

Deciding to support clinical research is one of the most consequential choices a government can make. Our latest survey of the clinical research workforce uncovers what's needed to bring more potentially lifesaving treatments to patients, and to improve the NHS. Deciding to support clinical research is one of the most consequential choices a government can make. Our latest survey of the clinical research workforce uncovers what's needed to bring more potentially lifesaving treatments to patients, and to improve the NHS.

by Joe Kiely | Opinion | 12 February 2024

12 February 2024

A microscope image showing cells affected by Barrett's oesophagus, a precancer that can lead to oesophageal cancer.

For oesophageal cancer awareness month, we’ve rounded up four of our articles on the latest research into oesophageal cancer diagnosis, treatment and prevention.   For oesophageal cancer awareness month, we’ve rounded up four of our articles on the latest research into oesophageal cancer diagnosis, treatment and prevention.  

by Amy Warnock | Analysis | 9 February 2024

9 February 2024

Cells with nuclei in blue and mitochondria (energy factories) in green.

Our researchers have found mutations that make cancers much more likely to respond to immunotherapy. It's a chance to make breakthrough treatments work for many more people. Our researchers have found mutations that make cancers much more likely to respond to immunotherapy. It's a chance to make breakthrough treatments work for many more people.

by Tim Gunn | Analysis | 31 January 2024

31 January 2024

Breast cancer cells taken as part of a biopsy shown under the microscope

New research we've funded has found that breast cancers can break down molecules in their support system to use as a source of nutrients. As healthy cells can't use this chemical pathway to make food, it could lead to a new targeted breast cancer treatment. New research we've funded has found that breast cancers can break down molecules in their support system to use as a source of nutrients. As healthy cells can't use this chemical pathway to make food, it could lead to a new targeted breast cancer treatment.

by Jacob Smith | Analysis | 17 January 2024

17 January 2024